US labels for Roche's Xenical and GSK's Alli add liver damage reports
This article was originally published in Scrip
Executive Summary
US labelling for the anti-obesity drug orlistat, marketed as Roche's prescription product Xenical and GlaxoSmithKline's over-the-counter formulation Alli, will reflect reports of rare but serious liver injury with the weight-loss products.